Sajjad highlights Manchester's Cancer Research Excellence

Sajjad has this last week met with Cancer Research UK scientists in Manchester to discuss and learn about the world class research taking place in the city.

He made a visit to the Paterson Institute for Cancer Research in Withington where he witnessed the range of groundbreaking scientific research currently being carried out there.

The Paterson Institute for Cancer Research forms part of the Manchester Cancer Research Centre and is core funded by Cancer Research UK. Together with other local organisations, including The Christie NHS Foundation Trust and the University of Manchester, the Paterson Institute is working towards becoming one of the world's leading cancer research centres.

Cancer Research UK scientists based at The Paterson Institute for Cancer Research work with other researchers and medical staff to take promising discoveries from the lab and develop them into potential treatments for cancer. They are currently developing new treatments for bowel, stomach, pancreatic and lung cancer.

 

Speaking after the visit, Sajjad said:

“This visit was a great opportunity to see some of the world class research that is being carried out right here in Manchester. The North West has some of the highest cancer rates when compared with other regions and my visit highlighted just why it is so important to support the vital research which could make a significant difference to the 36,100 people diagnosed with cancer across the region every year.

“Each year, there are an estimated 2.45 million new cancer cases and 1.23 million deaths from cancer in the EU. The Paterson Institute and other cancer research centres in the UK currently receive a large proportion of their funding from charitable sources, with very little funding coming from the European Union. Therefore as a Member of the European Parliament I will be pushing the European Commission for this to be increased in the future and for a greater availability of grant funding for scientists and researchers working in this important area.”

Professor Caroline Dive, who leads the Clinical and Experimental Pharmacology Group at the Paterson Institute, said:

“I was really pleased to welcome Sajjad Karim MEP to The Paterson Institute for Cancer Research to see for himself how we take cancer treatments ‘from the laboratory bench to the bedside’.

“It was a great opportunity to show how we are working with our partners across the Manchester Cancer Research Centre to help beat cancer. Collaboration is the key to the success of the Manchester Cancer Research Centre, which makes it easier for researchers to work alongside doctors treating patients on the ward. This enables patients to benefit as soon as possible from any breakthroughs in research.”

Last year, Cancer Research UK spent over £16 million on research in Manchester.  Much of this funding goes towards the pioneering work of the doctors and scientists at the Paterson Institute for Cancer Research.